tiprankstipranks
Advertisement
Advertisement

NVAX Stock Latest News

Novavax Updates Pediatric COVID-19 Vaccine Trial: What Investors Should Watch
Company AnnouncementsNovavax Updates Pediatric COVID-19 Vaccine Trial: What Investors Should Watch
9d ago
NVAX
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
PremiumThe Fly
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
16d ago
AZN
BMY
Trump confirms Kyle Diamantas to be acting head of FDA
PremiumThe Fly
Trump confirms Kyle Diamantas to be acting head of FDA
19d ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
PremiumThe Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
19d ago
AZN
BMY
Kennedy driving vast vaccine inquiry despite toned-down criticism, NYT says
PremiumThe Fly
Kennedy driving vast vaccine inquiry despite toned-down criticism, NYT says
20d ago
AZN
BMY
Unusually active option classes on open May 11th
PremiumThe FlyUnusually active option classes on open May 11th
20d ago
GTM
Trump Trade: U.S. plans AI security order without required model tests
Premium
The Fly
Trump Trade: U.S. plans AI security order without required model tests
20d ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
Premium
The Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
20d ago
DYN
RNA
Novavax reports Q1 EPS (6c), consensus (23c)
PremiumThe Fly
Novavax reports Q1 EPS (6c), consensus (23c)
24d ago
NVAX
Novavax price target raised to $9 from $8 at TD Cowen
PremiumThe Fly
Novavax price target raised to $9 from $8 at TD Cowen
24d ago
SNY
NVAX
Unusually active option classes on open May 6th
PremiumThe Fly
Unusually active option classes on open May 6th
24d ago
AG
DIS
Novavax Earnings Call: Partnerships, Cash Runway and Profit Path
PremiumCompany Announcements
Novavax Earnings Call: Partnerships, Cash Runway and Profit Path
24d ago
NVAX
TD Cowen’s Steve Scala Maintains Hold on NVAX, Nudges Price Target Up Amid Improved Tolerability Data but Limited Real‑World Effectiveness Evidence
PremiumRatingsTD Cowen’s Steve Scala Maintains Hold on NVAX, Nudges Price Target Up Amid Improved Tolerability Data but Limited Real‑World Effectiveness Evidence
26d ago
NVAX
FDA blocked publication of studies showing Covid vaccine safe, NYT says
Premium
The Fly
FDA blocked publication of studies showing Covid vaccine safe, NYT says
26d ago
AZN
BMY
NVAX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
NVAX Upcoming Earnings Report: What to Expect?
27d ago
NVAX
Novavax: COMPARE Study Underscores Safety Edge of Nuvaxovid and Supports Upside from Royalties, Milestones, and Licensing
PremiumRatings
Novavax: COMPARE Study Underscores Safety Edge of Nuvaxovid and Supports Upside from Royalties, Milestones, and Licensing
1M ago
NVAX
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
PremiumThe Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
2M ago
DYN
RNA
Novavax price target raised to $18 from $16 at B. Riley
PremiumThe Fly
Novavax price target raised to $18 from $16 at B. Riley
2M ago
NVAX
Novavax call volume above normal and directionally bullish
PremiumThe Fly
Novavax call volume above normal and directionally bullish
2M ago
NVAX
District court rules federal limits to vaccines not based on science, NYT says
PremiumThe FlyDistrict court rules federal limits to vaccines not based on science, NYT says
3M ago
AZN
BMY
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
3M ago
AZN
BMY
Novavax Earnings Call Signals Leaner, Partner-Led Future
Premium
Company Announcements
Novavax Earnings Call Signals Leaner, Partner-Led Future
3M ago
NVAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >